Application Sponsors
| ANDA 040190 | ELITE LABS INC | |
Marketing Status
Application Products
| 001 | TABLET;ORAL | 37.5MG | 0 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 1997-05-30 | |
| LABELING; Labeling | SUPPL | 2 | AP | 1999-05-07 | |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1999-09-02 | |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2002-11-14 | |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 15 | AP | 2013-11-08 | |
| LABELING; Labeling | SUPPL | 17 | AP | 2017-05-31 | STANDARD |
Submissions Property Types
| SUPPL | 3 | Null | 0 |
| SUPPL | 4 | Null | 0 |
| SUPPL | 15 | Null | 15 |
| SUPPL | 17 | Null | 15 |
TE Codes
CDER Filings
ELITE LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 40190
[companyName] => ELITE LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"37.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"37.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)